Researchers at NorthStrive Biosciences have filed a patent for a new probiotic called EL-22, designed to combat muscle-wasting conditions. This probiotic targets muscle loss that can occur due to various factors, including treatments for weight loss, aging, and certain neurological disorders. By focusing on muscle preservation, EL-22 aims to help people maintain their strength and overall health as they age or undergo specific medical treatments.

This development matters because muscle health is crucial for maintaining mobility and independence as we grow older. Muscle loss, known as sarcopenia, can lead to frailty and increase the risk of falls and injuries. If successful, EL-22 could offer a new way for people, especially those on weight-loss medications or dealing with muscle atrophy, to preserve their muscle mass and strength, potentially improving their quality of life.

The patent application is an early step in the development of EL-22, which means that while the concept is promising, it has not yet been proven effective in large-scale human trials. The filing indicates that NorthStrive is serious about protecting its innovation and advancing research in muscle health. However, it’s important to note that this is still in the early stages, and more evidence is needed to confirm the probiotic’s benefits for muscle preservation.

For now, staying active and incorporating strength training into your routine can help maintain muscle health. If you are considering weight-loss treatments, discussing potential effects on muscle mass with your healthcare provider can also be beneficial.

Source: longevity.technology